Newsletter | January 23, 2023

01.23.23 -- Using Biorelevant Predictive Tools To Develop Optimal Oral Formulations

Enhancing Bioavailability For Early Development Phase Molecules

An agile, parallel, and cross-functional approach, powered by a silo-free organization structure, will help in bringing an effective dosage form to market faster. These tools and processes can help.

Amorphous And Co-Amorphous Systems For Poorly Soluble Drugs

This webinar provides an overview of co-amorphous research and its recent findings, particularly the impact of low molecular weight excipient on developability, stability, and solubility. Experts discuss the amorphous dispersion formulation via spray drying and hot melt extrusion.

Developing Optimal Formulations Using Biorelevant Predictive Tools And Advanced Bioavailability Enhancement Technologies

API-sparing development techniques and identification of the appropriate scalable formulation technology to improve drug solubility and enhance oral bioavailability can help increase your chances of success when moving from preclinical development to early-phase clinical trials.

Advanced Analytical Tools For Drug Product Development

Gain insights into the applications of analytical techniques including Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS).